Garwood Medical Devices is developing two therapeutic electrode-powered products based on licences from University of Buffalo, having last raised $3.6m in 2016.
Garwood Medical Devices, a US-based therapeutic electrode device developer based on University of Buffalo research, is seeking $3m for its series B round, the university revealed yesterday.
None of the round’s potential participants have been named and it is unclear whether Garwood has already secured capital.
Founded in 2014, Garwood Medical Devices is developing two electrode-centred medical devices that help promote wound healing and prevent infection in metal orthopaedic implants such as prosthetic joints.
Garwood’s first product, the Biofilm Disruption Device (BDD), tackles implant infections by delivering a low-voltage current that prompts a chemical reaction on the implant’s surface to kill and repel bacteria.
The technology consists of a low-voltage power source, two electrode skin patches and a small needle inserted into the body to transfer a charge to the prosthesis.
BDD was conceived in the lab of Mark Ehrensberger, an assistant professor in the Department…
